3-23917962-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_002948.5(RPL15):c.103G>A(p.Ala35Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000267 in 1,461,476 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.000027 ( 0 hom. )
Consequence
RPL15
NM_002948.5 missense
NM_002948.5 missense
Scores
5
14
Clinical Significance
Conservation
PhyloP100: 4.31
Genes affected
RPL15 (HGNC:10306): (ribosomal protein L15) Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of four RNA species and approximately 80 structurally distinct proteins. This gene encodes a member of the L15E family of ribosomal proteins and a component of the 60S subunit. This gene shares sequence similarity with the yeast ribosomal protein YL10 gene. Elevated expression of this gene has been observed in esophageal tumors and gastric cancer tissues, and deletion of this gene has been observed in a Diamond-Blackfan anemia (DBA) patient. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. [provided by RefSeq, Mar 2017]
NKIRAS1 (HGNC:17899): (NFKB inhibitor interacting Ras like 1) Predicted to enable GTPase activating protein binding activity. Predicted to be involved in I-kappaB kinase/NF-kappaB signaling. Predicted to act upstream of or within several processes, including Ral protein signal transduction; lung alveolus development; and surfactant homeostasis. Located in cytosol and endoplasmic reticulum. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.27570784).
BS2
High AC in GnomAdExome4 at 39 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPL15 | NM_002948.5 | c.103G>A | p.Ala35Thr | missense_variant | 2/4 | ENST00000307839.10 | NP_002939.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPL15 | ENST00000307839.10 | c.103G>A | p.Ala35Thr | missense_variant | 2/4 | 1 | NM_002948.5 | ENSP00000309334 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD3 exomes AF: 0.00000802 AC: 2AN: 249400Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135402
GnomAD3 exomes
AF:
AC:
2
AN:
249400
Hom.:
AF XY:
AC XY:
2
AN XY:
135402
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000267 AC: 39AN: 1461476Hom.: 0 Cov.: 31 AF XY: 0.0000248 AC XY: 18AN XY: 727042
GnomAD4 exome
AF:
AC:
39
AN:
1461476
Hom.:
Cov.:
31
AF XY:
AC XY:
18
AN XY:
727042
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 06, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 1306432). This variant has not been reported in the literature in individuals affected with RPL15-related conditions. This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 35 of the RPL15 protein (p.Ala35Thr). This variant is present in population databases (no rsID available, gnomAD 0.002%). - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jun 11, 2019 | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;T;T;T;T;.;.;.;T;T;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;D;D;.;.;D;D;D;.;.;D;.
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;.;N;.;N;N;.;N;.;N;N;.;N
MutationTaster
Benign
D;D;D;D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;.;N;N;N;.;N;N;N;.;.;N
REVEL
Uncertain
Sift
Benign
T;T;.;T;T;T;.;T;T;T;.;.;T
Sift4G
Benign
T;T;T;T;T;T;.;T;T;T;.;.;T
Polyphen
B;.;B;.;B;B;.;.;.;B;B;.;B
Vest4
MutPred
Gain of phosphorylation at A35 (P = 0.0336);Gain of phosphorylation at A35 (P = 0.0336);Gain of phosphorylation at A35 (P = 0.0336);Gain of phosphorylation at A35 (P = 0.0336);Gain of phosphorylation at A35 (P = 0.0336);Gain of phosphorylation at A35 (P = 0.0336);Gain of phosphorylation at A35 (P = 0.0336);Gain of phosphorylation at A35 (P = 0.0336);Gain of phosphorylation at A35 (P = 0.0336);Gain of phosphorylation at A35 (P = 0.0336);Gain of phosphorylation at A35 (P = 0.0336);Gain of phosphorylation at A35 (P = 0.0336);Gain of phosphorylation at A35 (P = 0.0336);
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at